Tuesday, June 30, 2020
An hour-long Unleashing India Web Summit Series on Post Covid Devastation; Enhanced Role of Pharma & Drug Enterprises for National Reincarnation was held by The Policy Times (https://thepolicytimes.com/) on Tuesday, June 30 from New Delhi to discuss how Covid- 19 had caused an impact on Enhanced Role of Pharma & Drug Enterprises for National Reincarnation and how different sectors can contribute in India’s National Growth. The show started with a video clip of the speech of Prime Minister Narendra Modi on Covid- 19 and its effect on the country.
The web summit was chaired by Dr P. Sekhar, the Chairman of Global Smart City Panel MTGF, introduced by Mr. Akram Haque, The Founder- Editor of The Policy Times, and was moderated by Dr. Ranjit Barshikar, CEO of QbD International, United Nations Advisor, Editorial Board Member of Journal of generic Medicine, UK with eminent expert panellists including Dr. Dinesh Dua, Executive Director, M/S Nectar Lifesciences Ltd. India, Chairman of Pharmexcil, Ministry, Commerce, GOI and Mr. Lion Dara B. Patel, Secretary General of Indian Drug Manufacturers Association.
The chair of the session, Dr. P Sekhar said, “Our country is home to more than 3,000 pharma companies with a strong network of over 10, 500 manufacturing facilities.” He also added to his statement, “India ranks third worldwide for production by volume and ninth by value. India is the largest provider of generic medicines globally; occupying 20% share in global supply by volume and also supplies 62% of global demand for vaccines.”
Video Link: https://www.youtube.com/watch?v=VnQKsv53-XA
Dr. Ranjit Barshikar moderated the show for the day, he said, “The Pharmaceutical industry has been very much responsible for the whole world during this pandemic situation. Our industry leaders in reality have provided the innumerable supply of medicine to the world and the industry is managing the workforce and the work very effectively and handling successfully evolving government restrictions all around due to this pandemic situation. Mainly keeping in mind the consumers and the patients at large globally our role has been appreciated by several countries about our contribution during this crisis situation”.
Mr. Akram Hoque made his introductory remarks by explaining the health care industry as well as focusing on Pharma & Drug industry. He explained, “Health care is one of the core and necessary sectors of a country, but there are various aspects of looking at it, most importantly from the people’s perspective, where a small portion of society are highly rich and they have large amount of money to spend on health care, a large portion of the society are middle class who opt for government health care
but despite not getting good health care opt for private health care and a larger section who are poor or belongs to lower middle class opt for government hospitals and public sector health care”.
He also added, “When government forms any policy it is recommended that they should keep all this three sections in mind. And today we are here to discuss the role of Pharma and Drug Enterprises, because certainly India is one of the hubs of global health care and how this Pharma and Drug Enterprises can make India one of the centres of the world health care system and lead to massive amount of national growth, because if India can be a leader in any sector then it should be Pharma to begin with”.
Mr. Dinesh Dua explained the situation by throwing light about the overall impact of pandemic on our exports and imports scenario. Mr. Dua said, “India has always been on the forefront, since 1979, it has been one of the then leading companies. At that point of time we were the net importers of everything and had been signed off on broader line in terms of importation. In between the lockdown in May it has recorded the highest ever business in the world of $2.2 billion which executed a growth of 27% in such pandemic situation. And seeing this excellence the US President Trump called PM Modi for the supply of hydroxychloroquine, we gave 100+ countries free of cost HCQ along with Paracetamol. He also added that we have created a SOP and show it to the officers and work accordingly to the SOP following the norms and Covid is an eye- opener, how we can do thing managing everything and to overcome the challenges our employees worked even 18hours per day”.
Focusing on the fact of what has happened to Indian Pharma Industries and what changes have happened. Mr. Lion Dara B. Patel stated, “With the lockdown there were many challenges as there was hardly any time to gear up and to provide a large amount of medicines to different parts, we need man power, transport, raw materials for packaging and that was a challenge and the state board branches and
everybody geared up somehow we were able to get some passes for transportation of materials and people and that’s how production started”.
“In spite of different challenges and problems the government supported us and exchanged ideas with all the government officials and every official was so prompt and this helped a lot and the capacity utilisation which was as low as 20-25 per cent in March and April went up to 60- 70 per cent in May and June and many companies have went to 100% now. We also had a problem of getting materials from the factory to the stockade and from the stockade to the retailer. From the mid may situation improved and every companies had stock of 40 to 45 days and thus there is no need to panic. Covid has given us a lot to learn and now it is known “New Normal”.
Mr. Barshikar ended the show by thanking both the experts and said that the future is in secured hands. Mr. Barshikar added, “The hopes which you have given to the audience on the future in India on how it is going to be like and the opportunities in the industry as well and as our industry from the beginning is positive under every circumstances and therefore in near future we will overcome these issues and we will go back to the previous new normal which was earlier. Our Indians and also the global pharma industries are trying their best in manufacturing of the vaccine, thus, we do not need to worry about Covid anymore”.
About the Policy Times
The Policy Times has been organising innumerable Webinars and virtual conferences globally on perhaps all kinds of issues that are needed especially in this Covid- 19 situation, starting from the Students Career guidance, as students now are the future of the world to even discussing about the Post Covid- 19 devastation.
Established on March 2017, The Policy Times is a Delhi- based media cum strategic and practical Alliance of Policy and Business Experts for right Policy and business connect leading to prosperity of
society specializing through practical networking, Events, Business intelligence and research from our offices in Delhi, Mumbai, Nagpur, Chennai, Hyderabad, Kolkata etc. Policy Times is central Ministries and state governments, Embassy and High Commissions, India’s and World’s business association and export promotion agencies.
Soical Media links-